Central Serous Chorioretinopathy After Scalp And Eyebrow Intralesional Triamcinolone Acetonide Injections: Report Of Two Cases

July 2024 in “ JAAD Case Reports ”

Deesha Desai, Ambika Nohria, Lina Alhanshali, Michael Buontempo, Kristen I. Lo Sicco, Craig M. Fern, Jerry Shapiro

triamcinolone acetonide intralesional triamcinolone acetonide alopecia areata corticosteroids IL-TAC AA

From the encyclopedia

autoimmune disorder causing patchy hair loss

Studysummary This study reports two cases of central serous chorioretinopathy developing after intralesional corticosteroid injections to the scalp for alopecia areata, suggesting a potential association that warrants cautious use and monitoring for ocular complications.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

This report presents two cases of central serous chorioretinopathy (CSC) following intralesional triamcinolone acetonide (IL-TAC) injections for alopecia areata (AA). A 58-year-old female developed CSC after 4 months of IL-TAC treatment, which improved upon dose reduction. A 34-year-old male developed CSC after receiving IL-TAC injections to the scalp and eyebrows, with symptoms resolving upon discontinuation of IL-TAC. These cases highlight a potential link between IL-TAC injections and CSC, suggesting the need for caution and monitoring when using corticosteroids for localized treatments. Further research is needed to understand the mechanisms and risk factors involved.

View this study on jaadcasereports.org →

Discuss this study in the Community →

Research cited in this study

1 / 1 results

research Central Chorioretinopathy Associated with Topical Use of Minoxidil 2% for Treatment of Baldness

9 citations , September 2011 in “Cutaneous and Ocular Toxicology”

This article presents a case of central serous chorioretinopathy occurring after the use of topical minoxidil solution, but reports no clinical study findings.